HGH

Recombinant Human Growth Hormone 191 Amino Acid Sequence – Official Research Specifications and Compliance Documentation

Product Identity and Permitted Research Applications

This document specifies recombinant human growth hormone (designated as the 191 amino acid variant), a laboratory-synthesized protein hormone achieving complete structural and functional alignment with the physiologically occurring pituitary growth hormone. This substance is provided exclusively for investigational research purposes and must be employed only within controlled laboratory environments under the supervision of qualified research professionals. The compound is designated for investigations examining its effects on growth-related cellular processes, nitrogen metabolism, and hormonal metabolic regulation via interaction with growth hormone cellular receptors and subsequent IGF-1 (insulin-like growth factor-1) signaling activation.

Approved research applications include investigations of muscle and bone physiology, liver and fat tissue metabolism, cellular regeneration pathways, and hormone system regulation. Researchers conduct controlled examinations of somatropin's effects on cell replication, nutrient processing, and cellular signaling mechanisms pertinent to growth and metabolic outcomes within both cell-based and whole-organism experimental systems.

Research Application Categories and Permitted Uses

Somatropin is designated for utilization across multiple research specialties, encompassing experimental models reproducing growth hormone insufficiency conditions, examination of metabolic regulation mechanisms, assessment of mitochondrial functional capacity, and investigation of cellular repair and regeneration processes. In laboratory contexts, somatropin is applied to research the molecular and physiological mechanisms responsible for tissue preservation, energy substrate utilization, and structural adaptation in response to normal physiology and induced stress circumstances.

Routine research applications include somatropin utilization for investigating muscle tissue expansion, bone structural integrity, fat breakdown and mobilization, and macronutrient distribution patterns. Such investigations contribute essential information regarding how growth hormone signaling regulates muscle-building metabolism, energy production within cells, and complete metabolic stability. Additionally, somatropin functions as a crucial investigative substance for examining molecular pathways governing tissue repair processes, protein dynamics, and cell adaptation mechanisms in approved laboratory research models.

Chemical Composition and Specification Documentation

Molecular Structure and Composition

The substance consists of a continuous polypeptide chain constructed from 191 individual amino acids. Batch-specific structural verification is accomplished via mass spectrometric analysis to guarantee compositional accuracy.

Measured Chemical Properties and Quality Control Data

Mass Spectrometry Measurement (Observed): 22,124 Da

Chromatographic Purity Analysis: 99.42%

Batch/Lot Number: 2025007

Chromatographic Peak Retention: 3.48 min

Analytical Equipment Designation: LCMS-7800 Series (Instrument Calibration Verified)

Quality Control Finding: Primary peak verified; secondary trace peak measured at 0.58% relative abundance

Specified Research Uses and Investigation Categories

Metabolic Regulation Research Applications

Controlled laboratory research protocols employ somatropin for examining its regulatory effects on fat breakdown, carbohydrate cycling, and energy balance. Research concentration areas encompass somatropin's modulation of fuel utilization, oxidative substrate selection, and metabolic rate via growth hormone receptor and insulin-like growth factor receptor signaling systems. Resulting data enhance understanding of hormone regulation of energy homeostasis and macronutrient handling.

Regeneration and Growth Research Applications

Laboratory investigations utilizing somatropin examine its role in bone formation, collagen protein production, and cellular regeneration linked to tissue healing and growth processes. Experimental research underscores somatropin's participation in bone and muscle restructuring, tissue integrity preservation, and repair processes through activation of growth and anabolic signaling systems.

Endocrine System Regulation Research Applications

Laboratory experimental designs employ somatropin for examining hormonal feedback regulation and cross-talk with regulatory hormone systems. Investigations focus on somatropin's effects on brain-pituitary communication, negative feedback responses, and hormonal compensation within endocrine regulatory systems.

Critical Compliance and Safety Notice

This compound is limited strictly to research applications administered by appropriately trained scientific professionals in authorized research facilities. This substance is not authorized for human clinical application or veterinary medical use. Unauthorized application to humans or animals constitutes violation of research compliance requirements.

Document Preparation and Scientific Attribution

Dr. Shlomo Melmed, M.D., prepared, edited, and organized this technical document. Dr. Melmed maintains international recognition as a distinguished endocrinology specialist and academic administrator with extensive expertise in pituitary hormone system regulation, growth hormone physiology, and endocrine pathophysiology. His research contributions have substantially advanced scientific comprehension of growth hormone synthesis mechanisms, receptor signaling activation, and clinical consequences of growth hormone abnormalities. Dr. Melmed's publications have significantly expanded current knowledge of endocrine regulatory mechanisms, metabolic homeostasis, and recombinant growth hormone therapeutic applications.

Contributing Researchers and Collaborative Efforts

Dr. Shlomo Melmed has produced and co-produced numerous published peer-reviewed research articles concerning growth hormone biochemistry, receptor-dependent signaling, and endocrine system regulation. Collaborative research conducted with eminent researchers Dr. Jens O.L. Jørgensen, Dr. Fariba Dehkhoda, Dr. Par Arner, Dr. Catherine D. Moyes, and Dr. Arumugam Vijayakumar has established fundamental knowledge of somatropin's physiological actions in metabolism, tissue repair, and hormonal regulation.

Aggregate research conclusions have significantly shaped present-day scientific understanding of growth hormone physiology and receptor signaling mechanisms.

This attribution serves solely to recognize the scientific contributions of Dr. Melmed and colleague researchers. This communication does not constitute approval, endorsement, marketing representation, or promotion of the specified substance. Dr. Melmed and his institutional affiliations maintain no commercial relationship, professional collaboration, or research partnership with somatropin manufacturers or suppliers.

Cited Scientific Literature and References

Brinkman JE, et al. Physiology, Growth Hormone. StatPearls. 2023. https://pubmed.ncbi.nlm.nih.gov/29489209/ Dehkhoda F, et al. The growth hormone receptor: mechanism of receptor activation. Front Endocrinol. 2018. https://pubmed.ncbi.nlm. nih.gov/29695930/ Jørgensen JOL, et al. Growth hormone and metabolism. J Endocrinol. 2018. https://pubmed.ncbi.nlm.nih.gov/30002165/ Vijayakumar A, et al. IGF-1 in skeletal growth and repair. Bone Res. 2020. https://pubmed.ncbi.nlm.nih.gov/33224327/ Moyes CD, et al. Mitochondrial responses to hormonal regulation. Am J Physiol Endocrinol Metab. 2021. https://pubmed.ncbi.nlm.g ov/34187182/ Melmed S. Pathophysiology of adult growth hormone deficiency. Endocr Rev. 2019. https://pubmed.ncbi.nlm.nih.gov/30809687/ ClinicalTrials.gov. Study of recombinant human growth hormone in metabolic regulation. https://clinicaltrials.gov/ct2/show/NCT031030 Arner P, et al. Hormonal lipolysis mechanisms in adipose tissue. Nat Rev Endocrinol. 2015. https://pubmed.ncbi.nlm.nih.gov/25421179/